Professor Colin Dayan



Prosiectau fel Prif Ymchwiliwr
null null 7 o 7 null null

Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger smarter faster - Cyllidwr:Juvenile Diabetic Research Foundation, - Cyllidwr:Diabetes UK (01.05.2019 - 30.04.2022)
The beta-2 score and beyond: new composite outcomes measures of islet cell function for use in clinical trials - Cyllidwr:Juvenile Diabetic Research Foundation (01.10.2019 - 30.09.2022)
Reducing the impact of diabetic foot ulcers on patients and the health service: The REDUCE programme - Cyllidwr:National Institute for Health Research (01.03.2020 - 31.12.2025)


Prosiectau fel Cyd-Ymchwiliwr
null null 2 o 3 null null

Development of urinary microRNAs as biomarkers for diabetic kidney disease - Cyllidwr:National Institute for Health Research (01.04.2013 - 31.07.2018)
Microneedle technology to deliver peptide immunotherapy for type 1 diabetes - Cyllidwr:The Novo Nordisk UK Research Foundation (01.08.2011 - 31.08.2015)
Cardiovascular disease research - Cyllidwr:Cardiac Research & Development Fund (01.11.2013 - 31.10.2016)

Diweddarwyd y tro diwethaf ar 2020-02-08 am 04:07